Effectiveness of a One-year Group Program for Fatigue Management in Mi
Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis: a Non-randomized, Open-label, Controlled Clinical Trial
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Fatigue management program
What it measured
Main measures
To determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in reducing the severity of perceived fatigue by the Modified Fatigue Impact Scale (MFIS).
(12 months after the start of the program) and at mid-term follow-up (18 months)
Thinking and memoryFatigueArm and hand function
Other measures (6)
To determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in improving self-efficacy by the 4-item Spanish chronic disease self - efficacy.
(12 months after the start of the program) and at mid-term follow-up (18 months)
To determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in improving incidental and planned exercise by the International Physical Activity Questionnaire (IPAQ)
(12 months after the start of the program) and at mid-term follow-up (18 months)
Walking and mobilityPhysical functionTo determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in improving sleep quality by the Pittsburgh Sleep Quality Index (PSQI).
(12 months after the start of the program) and at mid-term follow-up (18 months)
Mood and sleepTo determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in Reducing anxiety and depression levels by the Hospital Anxiety and Depression Scale (HADS).
(12 months after the start of the program) and at mid-term follow-up (18 months)
FatigueBladder, bowel and sexual functionMood and sleepTo determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in reducing the impact of fatigue on health status by the EQ-5D-5L.
(12 months after the start of the program) and at mid-term follow-up (18 months)
FatigueWalking and mobilityPainMood and sleepQuality of life (reported by participants)To determine the effectiveness of this program after completion (12 months after the start of the program) and at mid-term follow-up (18 months) in improving quality of life by the SF-36 questionnaire.
(12 months after the start of the program) and at mid-term follow-up (18 months)
PainQuality of life (reported by participants)
Who could take part
MS (type not specified) · Up to 70
Show the full criteria
Inclusion criteria
* Patients diagnosed with multiple sclerosis referred by the Neuroimmunology and Multiple Sclerosis Unit at Hospital Clínic de Barcelona who present symptoms of limiting fatigue. * Independence to perform basic activities of daily living. * Maximum EDSS score of 4.5. Inclusion criteria for control group participants: * Patients who, despite meeting the inclusion criteria (6.1), are unable to attend the sessions (due to availability, geographic location, or other personal reasons) will be included in the comparison group. or * Those who show a lack of attendance at sessions of \<80% over the course of a year or \<75% in one of the quarters.
Exclusion criteria
* Severe comorbidity due to other conditions, including severe depressive symptoms, or substance use that may impact the individual's self-perception. * MS flare within 30 days prior to inclusion.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Fatigue is one of the most common symptoms, experienced by between 50% and 100% of people with multiple sclerosis (MS), and contributes significantly to the consequences of MS and perceived disability in the daily lives of those with the condition. On the one hand, practicing different forms of physical exercise (PE) has demonstrated effective management of perceived fatigue, and the literature strongly supports the need for regular exercise in patients with MS. On the other hand, energy conservation programs and cognitive-behavioral interventions have demonstrated improvements in self-efficacy, participation in social life, perceived control over their disease, and a reduction in the perceived impact of fatigue, particularly in the physical and psychosocial domains of life. Therefore, in this study, a physical therapist and an occupational therapist will conduct a one-year group program focused on educational and practical learning of techniques and strategies, keeping in mind that lifestyle changes take time to become permanent. It is important to highlight that, as MS generally presents in early adulthood, there is growing interest in exploring rehabilitation techniques very early after diagnosis or in minimally affected MS patients (0-4.5 on the EDSS), we are therefore interested in exploring this program in this population group with MS, the majority of whom are actively employed, and evaluating the effects on perceived fatigue severity, quality of life, incidental and planned exercise, sleep quality, anxiety and depression, and perceived self-efficacy. Study participants will be recruited by the neuroimmunology team at Hospital Clínic de Barcelona, who will select those who meet the inclusion criteria from the multiple sclerosis patients seen. Those patients who, despite meeting the inclusion criteria, are unable to attend the sessions (due to availability, geographic location, or other personal reasons) will form the comparison group. Therefore, there is no random assignment in this study. For this study, a total sample of 28 patients will be divided into three groups of 7, 7, and 14 participants, respectively. The last group will not receive treatment and will be used as a control group. Patients who do receive treatment will be assigned to groups on a first-come, first-served basis, and the therapeutic program will be the same for both groups. This separation is done to improve the quality of the intervention by allowing participants greater interaction in small groups. Participants who must withdraw from the study for reasons beyond their control, having completed less than a third of the program, and participants who, despite being considered good candidates, are unable to attend the sessions for work, personal, or geographic reasons, will be evaluated at the beginning and end of the study using the same scales as the control group to compare the results obtained. The sessions will be held at the day hospital for neurodegenerative diseases at the Hospital Clínic de Barcelona, twice a week: one physiotherapy session and one occupational therapy session. Implicit assessments will be conducted at the start of the program, at 6 months, one year, and 6 months after completion of the program. There are no risks beyond the risks inherent in sports practice, which may exist in physical therapy sessions.
Loading reviews and guidelines…
History
Started
Mar 2025
Main results due
Mar 2026
Finished
Sept 2026